Jason R. Cannon, PhD - Publications

Affiliations: 
Purdue University, West Lafayette, IN, United States 

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Weera MM, Agim ZS, Cannon JR, Chester JA. Genetic correlations between nicotine Reinforcement-Related behaviors and propensity toward high or low alcohol preference in two replicate mouse lines. Genes, Brain, and Behavior. e12515. PMID 30129253 DOI: 10.1111/gbb.12515  0.72
2018 Adamson SX, Shen X, Jiang W, Lai V, Wang X, Shannahan JH, Cannon JR, Chen J, Zheng W. Subchronic manganese exposure impairs neurogenesis in the adult rat hippocampus. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 29579278 DOI: 10.1093/toxsci/kfy062  0.4
2018 Cruz-Hernandez A, Agim ZS, Montenegro PC, McCabe GP, Rochet JC, Cannon JR. Selective dopaminergic neurotoxicity of three heterocyclic amine subclasses in primary rat midbrain neurons. Neurotoxicology. PMID 29408373 DOI: 10.1016/j.neuro.2018.01.009  0.72
2018 Agim ZS, Cannon JR. Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure. Toxicology Letters. 287: 31-41. PMID 29378243 DOI: 10.1016/j.toxlet.2018.01.017  0.72
2017 Sammi SR, Agim ZS, Cannon JR. Harmane-induced selective dopaminergic neurotoxicity in C. elegans. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 29069497 DOI: 10.1093/toxsci/kfx223  0.72
2017 Park J, Lee JW, Cooper SC, Broxmeyer HE, Cannon JR, Kim CH. Parkinson disease-associated LRRK2 G2019S transgene disrupts marrow myelopoiesis and peripheral Th17 response. Journal of Leukocyte Biology. PMID 28751472 DOI: 10.1189/jlb.1A0417-147RR  1
2016 Dukes AA, Bai Q, Van Laar VS, Zhou Y, Ilin V, David CN, Agim ZS, Bonkowsky JL, Cannon JR, Watkins SC, Croix CM, Burton EA, Berman SB. Live imaging of mitochondrial dynamics in CNS dopaminergic neurons in vivo demonstrates early reversal of mitochondrial transport following MPP(+) exposure. Neurobiology of Disease. PMID 27452482 DOI: 10.1016/j.nbd.2016.07.020  1
2015 Zharikov AD, Cannon JR, Tapias V, Bai Q, Horowitz MP, Shah V, El Ayadi A, Hastings TG, Greenamyre JT, Burton EA. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model. The Journal of Clinical Investigation. PMID 26075822 DOI: 10.1172/JCI64502  1
2015 Wirbisky SE, Weber GJ, Sepúlveda MS, Xiao C, Cannon JR, Freeman JL. Developmental origins of neurotransmitter and transcriptome alterations in adult female zebrafish exposed to atrazine during embryogenesis. Toxicology. 333: 156-67. PMID 25929836 DOI: 10.1016/j.tox.2015.04.016  1
2015 Lee JW, Cannon JR. LRRK2 mutations and neurotoxicant susceptibility. Experimental Biology and Medicine (Maywood, N.J.). 240: 752-9. PMID 25888648 DOI: 10.1177/1535370215579162  1
2015 Robison G, Sullivan B, Cannon JR, Pushkar Y. Identification of dopaminergic neurons of the substantia nigra pars compacta as a target of manganese accumulation. Metallomics : Integrated Biometal Science. 7: 748-55. PMID 25695229 DOI: 10.1039/c5mt00023h  1
2015 Agim ZS, Cannon JR. Dietary factors in the etiology of Parkinson's disease. Biomed Research International. 2015: 672838. PMID 25688361 DOI: 10.1155/2015/672838  1
2015 Lee JW, Tapias V, Di Maio R, Greenamyre JT, Cannon JR. Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats. Neurobiology of Aging. 36: 505-18. PMID 25174649 DOI: 10.1016/j.neurobiolaging.2014.07.011  1
2014 Di Maio R, Cannon JR, Timothy Greenamyre J. Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats. Neurobiology of Disease. 73: 356-365. PMID 25447228 DOI: 10.1016/j.nbd.2014.10.018  1
2014 O'Neal SL, Lee JW, Zheng W, Cannon JR. Subacute manganese exposure in rats is a neurochemical model of early manganese toxicity. Neurotoxicology. 44: 303-13. PMID 25117542 DOI: 10.1016/j.neuro.2014.08.001  1
2014 Wirbisky SE, Weber GJ, Lee JW, Cannon JR, Freeman JL. Novel dose-dependent alterations in excitatory GABA during embryonic development associated with lead (Pb) neurotoxicity. Toxicology Letters. 229: 1-8. PMID 24875535 DOI: 10.1016/j.toxlet.2014.05.016  1
2014 Griggs AM, Agim ZS, Mishra VR, Tambe MA, Director-Myska AE, Turteltaub KW, McCabe GP, Rochet JC, Cannon JR. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is selectively toxic to primary dopaminergic neurons in vitro. Toxicological Sciences : An Official Journal of the Society of Toxicology. 140: 179-89. PMID 24718704 DOI: 10.1093/toxsci/kfu060  1
2014 Tapias V, Cannon JR, Greenamyre JT. Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease. Neurobiology of Aging. 35: 1162-76. PMID 24315037 DOI: 10.1016/j.neurobiolaging.2013.10.077  1
2014 Wang Y, Lee JW, Oh G, Grady SR, McIntosh JM, Brunzell DH, Cannon JR, Drenan RM. Enhanced synthesis and release of dopamine in transgenic mice with gain-of-function α6* nAChRs. Journal of Neurochemistry. 129: 315-27. PMID 24266758 DOI: 10.1111/jnc.12616  1
2013 Cannon JR, Geghman KD, Tapias V, Sew T, Dail MK, Li C, Greenamyre JT. Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment. Experimental Neurology. 240: 44-56. PMID 23153578 DOI: 10.1016/j.expneurol.2012.11.007  1
2013 Cannon JR, Greenamyre JT. Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models. Neurobiology of Disease. 57: 38-46. PMID 22776331 DOI: 10.1016/j.nbd.2012.06.025  1
2013 Greenamyre JT, Cannon JR, Sanders LH, Tapias V, Bai Q, Volpicelli-Daley L, Lee VM, Burton EA. Synuclein-Mitochondrial Interactions in Substantia Nigra Dopamine Neurons Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 126-127. DOI: 10.1016/B978-0-12-800044-1.00111-2  1
2012 Milanese C, Sager JJ, Bai Q, Farrell TC, Cannon JR, Greenamyre JT, Burton EA. Hypokinesia and reduced dopamine levels in zebrafish lacking β- and γ1-synucleins. The Journal of Biological Chemistry. 287: 2971-83. PMID 22128150 DOI: 10.1074/jbc.M111.308312  0.8
2011 Cannon JR, Greenamyre JT. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicological Sciences : An Official Journal of the Society of Toxicology. 124: 225-50. PMID 21914720 DOI: 10.1093/toxsci/kfr239  1
2011 Cannon JR, Sew T, Montero L, Burton EA, Greenamyre JT. Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra. Experimental Neurology. 228: 41-52. PMID 21056560 DOI: 10.1016/j.expneurol.2010.10.016  1
2010 Cannon JR, Greenamyre JT. Neurotoxic in vivo models of Parkinson's disease recent advances. Progress in Brain Research. 184: 17-33. PMID 20887868 DOI: 10.1016/S0079-6123(10)84002-6  1
2010 Greenamyre JT, Cannon JR, Drolet R, Mastroberardino PG. Lessons from the rotenone model of Parkinson's disease. Trends in Pharmacological Sciences. 31: 141-2; author reply . PMID 20096940 DOI: 10.1016/j.tips.2009.12.006  1
2010 Tapias V, Cannon JR, Greenamyre JT. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model. Journal of Neuroscience Research. 88: 420-7. PMID 19681169 DOI: 10.1002/jnr.22201  1
2009 Cannon JR, Greenamyre JT. NeuN is not a reliable marker of dopamine neurons in rat substantia nigra. Neuroscience Letters. 464: 14-7. PMID 19682546 DOI: 10.1016/j.neulet.2009.08.023  1
2009 Drolet RE, Cannon JR, Montero L, Greenamyre JT. Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology. Neurobiology of Disease. 36: 96-102. PMID 19595768 DOI: 10.1016/j.nbd.2009.06.017  1
2009 Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT. A highly reproducible rotenone model of Parkinson's disease. Neurobiology of Disease. 34: 279-90. PMID 19385059 DOI: 10.1016/j.nbd.2009.01.016  1
2007 Cannon JR, Xi G, Keep RF. Recent research on changes in genomic regulation and protein expression in intracerebral haemorrhage. International Journal of Stroke : Official Journal of the International Stroke Society. 2: 265-9. PMID 18705926 DOI: 10.1111/j.1747-4949.2007.00160.x  1
2007 Cannon JR, Hua Y, Richardson RJ, Xi G, Keep RF, Schallert T. The effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing. Behavioural Brain Research. 183: 161-8. PMID 17629581 DOI: 10.1016/j.bbr.2007.06.004  1
2006 Cannon JR, Keep RF, Schallert T, Hua Y, Richardson RJ, Xi G. Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson's disease. Brain Research. 1116: 177-86. PMID 16934779 DOI: 10.1016/j.brainres.2006.07.094  1
2006 Cannon JR, Nakamura T, Keep RF, Richardson RJ, Hua Y, Xi G. Dopamine changes in a rat model of intracerebral hemorrhage. Acta Neurochirurgica. Supplement. 96: 222-6. PMID 16671459 DOI: 10.1007/3-211-30714-1-48  1
2005 Cannon JR, Keep RF, Hua Y, Richardson RJ, Schallert T, Xi G. Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson's disease model. Neuroscience Letters. 373: 189-94. PMID 15619541 DOI: 10.1016/j.neulet.2004.10.089  1
Show low-probability matches.